Capsida Biotherapeutics Presents Data Demonstrating Unique Industry-Leading Technology and Capabilities With Potential to Treat Both Rare and Common Diseases at the Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
- Wednesday, May 18, 2022, 7:02
- Finance
- Add a comment
Platform utilizes combinatorial engineering and automation to screen in high-throughput, generating capsids greatly improved over AAV9 in CNS efficiency and specificity Process development and manufacturing data validate in-house capability to produce highly productive and scalable…
About the Author
adminasapcorp has written 41623 stories on this site.